Kee Lock Chua’s Post

Reflecting on 2024, the Vertex Global Platform proudly celebrates a remarkable year marked by 10 successful IPOs and strategic acquisitions across our diverse portfolio 🌍 In this video, our CEO Kee Lock Chua takes us through the significant milestones we've achieved together. These exits not only highlight the strength and resilience of our global Vertex Platform but also underscores our ability to navigate the complexities of the venture capital landscape. 🚀 IPOs: Septerna listed on Nasdaq Horizon Robotics on the Hong Kong Stock Exchange Boundless Bio on Nasdaq alt Inc. on the Tokyo Stock Exchange 🤝 Mergers & Acquisitions: Own Company acquired by Salesforce EyeBio acquired by Merck Codefresh acquired by Octopus Deploy Adaptive Shield, a CrowdStrike Company acquired by Crowdstrike AnHeart Therapeutics acquired by Nuvation Bio Evisort acquired by Workday A heartfelt thank you to all the Vertex teams and our portfolio companies for your hard work and dedication. Here’s to a successful year and many more milestones ahead! 🎉 #VertexHoldings #VentureCapital #IPOs #Acquisitions #Milestones #Innovation Vertex Ventures SE Asia & India Vertex Ventures Israel Vertex Ventures US Vertex Growth Vertex Ventures HC

Congratulations to the entire Vertex Global Platform team on an outstanding year! Celebrating 10 successful IPOs and strategic acquisitions is a testament to our collective hard work and dedication. It’s truly remarkable to witness the resilience and growth of our portfolio companies throughout this journey. Excited for what lies ahead as we continue to achieve great milestones together! 🚀🌍 #VertexVentures #VentureCapital #Innovation"

What a difference a year makes... In the first half alone: 💰 114 acquisitions valued at $40.3 billion — nearly surpassing last year’s total. 💰 $9.7 billion in venture funding, showcasing strong investor confidence. 📉 Fewer IPOs, but strategic deals are stealing the spotlight. This wave of activity signals MedTech’s push to expand capabilities, adopt new technologies, and strengthen market positions. Swipe 👉 to explore the top 5 MedTech M&A deals of 2024 and see who’s leading this transformative trend. -------- I help MedTech innovators build high-performing teams. DM to learn more. #MedTech #MergersAndAcquisitions #HealthcareInnovation #LifeSciences #MedTechDeals

🚀 Mergers are making a strong comeback, and there’s plenty for small-cap investors to seize! This year alone, M&A activity in the Americas has surged 43%, hitting $847 billion. With interest rates stable and optimism high, companies are gearing up for strategic acquisitions. Healthcare, with its upcoming patent expirations, looks particularly promising. Big pharma giants like Bristol Myers-Squibb and Amgen are eyeing smaller biotech firms to bolster their pipelines. Meanwhile, in tech, larger players are eyeing smaller AI-focused companies like C3.ai for their innovation potential. Exciting times ahead! https://lnkd.in/et3HK_-j #MergersAndAcquisitions #MAndA #LOKIGroup

Bringing some positivity from the Boston tech sector on a Monday, with a series of exciting developments in funding, acquisitions and mergers that have ocurred in the past couple of weeks. 💰 Mastercard are set to acquire Somerville cyber-security firm, Recorded Future for $2.65b 🧬 Superluminal, a Boston based generative biology biotech closed on $120m in Series A investment 💻 Progress Software announced an acquisition of a document sharing company for $875m 🧬 Bain Capital raised $3b, their largest fund to date to invest into the biotech industry 🧬NextRNA Therapeutics have signed a collaboration deal with Bayer AG Of course there are is still news of lay-offs occurring and examples of company's reducing in size, but it has been encouraging to hear some brighter news among the challenges in 2024 so far, long may it continue! #Boston #Technology #Market

For biotech companies eyeing the IPO window, proper preparation is the difference maker in being able to jump when opportunity arises. We have the experience, resources, and connections to help from end to end: https://lnkd.in/diRMrYkS Whether a traditional IPO, reverse merger, or alternative financing path, we provide strategic guidance and operational support in an efficient, fractional way, including coordination with Argot Partners for strategic communications and IR. Click below to learn more. #biotech #ipo #capitalmarkets https://lnkd.in/diRMrYkS

𝗠𝗲𝗱𝘁𝗲𝗰𝗵 𝗠&𝗔 𝗰𝗼𝘂𝗹𝗱 𝗯𝗲 𝗼𝗻 𝘁𝗵𝗲 𝗿𝗶𝘀𝗲 𝗶𝗻 𝟮𝟬𝟮𝟱 Analysts from Bank of America predict a favorable environment for mergers and acquisitions in the medtech space in 2025. https://lnkd.in/dqN7iYFH

Companies to Watch for Potential M&As in 2024 https://lnkd.in/gwNeNXVk Hand passing off bag of money over financial background/Taylor Tieden for BioSpace This year has seen a boom in biopharma mergers and acquisitions, with six acquisitions over a billion dollars so far. In light of [...]

Smaller drugmakers are now pivotal in biotech acquisitions, offering new liquidity options for startups and VCs. Driven by increased competition, better access to capital, and strategic growth needs, these acquisitions provide an alternative to IPOs, accelerating innovation and market access. This shift has diversified the biotech M&A landscape, creating a dynamic environment for growth and development, and promising exciting opportunities for the industry's future. #Biotech #Pharma #Mergers #Acquisitions #Innovation

Are you ready for the summer?   ‘Next wave of IPOs’ will arrive in summer, predicts biotech-focused VC partner   Medicxi's Francesco De Rubertis (second from right) spoke to Fierce Biotech after participating in a panel at the LSX World Conference on how biotechs can prepare for an IPO. (James Waldron) Delegates at the LSX World Conference in London this week seemed to agree on one thing—the biotech IPO window finally re-opened this year.   https://lnkd.in/e-zp2tkQ   #ipo #listings #securities #srfc